Ependymoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(Mahshid) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{AAM}} | {{CMG}} {{AE}} {{AAM}} | ||
==Overview== | ==Overview== | ||
Secondary prevention strategies following ependymoma include regular clinical assessment and [[neuroimaging | Secondary prevention strategies following ependymoma include regular clinical assessment and [[neuroimaging]].<ref name=Cancergov> Ependymoma. http://www.cancer.gov/types/brain/hp/child-ependymoma-treatment-pdq#link/_291_toc. URL Accessed on 10 07, 2015</ref> | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
* [[Neuroimaging]] coupled with clinical assessment are generally recommended after treatment for ependymoma.<ref name=Cancergov> Ependymoma. http://www.cancer.gov/types/brain/hp/child-ependymoma-treatment-pdq#link/_291_toc. URL Accessed on 10 07, 2015</ref> | * [[Neuroimaging]] coupled with clinical assessment are generally recommended after treatment for ependymoma.<ref name=Cancergov> Ependymoma. http://www.cancer.gov/types/brain/hp/child-ependymoma-treatment-pdq#link/_291_toc. URL Accessed on 10 07, 2015</ref> | ||
| Line 16: | Line 17: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] | |||
Latest revision as of 22:19, 26 November 2017
|
Ependymoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ependymoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Ependymoma secondary prevention |
|
Risk calculators and risk factors for Ependymoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Secondary prevention strategies following ependymoma include regular clinical assessment and neuroimaging.[1]
Secondary Prevention
- Neuroimaging coupled with clinical assessment are generally recommended after treatment for ependymoma.[1]
- MRI imaging of the brain and/or spinal cord every 3 months for the first 1 to 2 years after treatment.
- After 2 years, imaging every 6 months for the next 3 years is often undertaken.
References
- ↑ 1.0 1.1 Ependymoma. http://www.cancer.gov/types/brain/hp/child-ependymoma-treatment-pdq#link/_291_toc. URL Accessed on 10 07, 2015